The American college edifice [i]or[...

The American college edifice [i]or[/i] building of Cardiology/American Heart Association (ACC/AHA) Task Force onward Practice Guidelines recently issued a joint executive summary of guidelines for the management of ST-elevation myocardial infarction (STEMI). This "Practice Guideline" will focus in succession two sections of the guideline: hospital and long-term management. In the November 1 2004 issue of American Family Physician, a Practice Guideline discussed management before STEMI and initial recognition and management in the difficulty department sections of this guideline. The ACC/AHA guideline was published in the August 3 2004 issue of Circulation and is available online at http://www.acc.org/clinical/guidelines/stemi/index.htm.

This guideline focuses in succession advances in the diagnosis and management of STEMI since 1999 Recommendations for indications for a diagnostic step a particular therapy, or an intervention in patients with STEMI are based onward clinical evidence and expert opinion. Definitions of the evidence flushs are as follows: Level A: Data derived from multiple randomized clinical trials or meta-analyses. of the same height B: Data derived from a single randomized trial, or nonrandomized studies. horizontal C: Only consensus opinion of experienced persons case studies, or standard-of-care. Class I: measure or treatment should be performed or administered. Class IIa: It is reasonable to perform measure or administer treatment (additional studies with focused objectives needed) Class IIb: step or treatment may be considered (additional studies with broad objectives needed; additional registry data would be helpful). Class III: proceeding or treatment should not be performed or administered because it is not helpful and may be harmful (no additional studies needed)

Hospital Management EARLY, GENERAL MEASURES

of the same height of Activity

Class IIa

1 After 12 to 24 hours, it is reasonable to allow patients with hemodynamic instability or continued ischemia to have bedside chest of drawers privileges. (Level of Evidence: C)

Class III

1 Patients with STEMI who are unrestrained of recurrent ischemic discomfort, symptoms of heart failure, or serious disturbances of heart rhyme should not be on bed repose for more than 12 to 24 hours. (Level of Evidence: C)

Diet

Class I

1 Patients with STEMI should be prescribed the diet of the National Cholesterol Education Program Adult Treatment Panel III Therapeutic Lifestyle Changes, which focuses upon reduced intake of fats and cholesterol les than 7 percent of total calories as saturated fats, les than 200 mg of cholesterol by day, increased consumption of omega-3 fatty acids, and appropriate caloric intake for bottom needs. (Level of Evidence: C)

2 Patients with diabetes who have STEMI should have an appropriate nourishment group balance and caloric intake. (Level of Evidence: B)

3 Sodium intake should be restricted in STEMI patients with hypertension or heart failure. (Level of Evidence: B)

PATIENT EDUCATION IN THE HOSPITAL SETTING

Class I

1 Patient counseling to maximize adherence to evidence-based post-STEMI treatments (such as compliance with taking medication, exercise prescription, and smoking cessation) should begin during the early phase of hospitalization, flash on the mind intensively at discharge, and continue at follow-up visits with providers and end cardiac rehabilitation programs and community support clusters as appropriate. (Level of Evidence: C)

2 Critical pathways and protocols and other quality-improvement tools (such as the ACC "Guidelines Applied in Practice" and the AHA's "Get with the Guidelines") should be used to improve the application of evidence-based treatments by dint of patients with STEMI, caregivers, and institutions. (Level of Evidence: C)

Analgesia/Anxiolytics

Class IIa

1 It is reasonable to use anxiolytic medications in patients with STEMI to alleviate short-term anxiety or altered behavior related to hospitalization for STEMI. (Level of Evidence: C)

2 It is reasonable to routinely assess the patient's anxiety of the same height and manage it with behavioral interventions and referral for counseling. (Level of Evidence: C)

RISK STRATIFICATION DURING EARLY HOSPITAL COURSE

Risk stratification requires the updating of initial assessments with data obtained during the course of the hospital stay. The resort of chest pain and persistence of electrocardiogram findings indicating infarction are indicators of failed reperfusion. These patients should go through coronary angiography. Sudden onset of heart failure or port of a new murmur herald increased risk and recommend the need for rapid intervention. For those who did not go through primary reperfusion, changes in clinical status may herald a worsening clinical status and are an indication for coronary angiography. Patients with a gentle risk of complications may be considered for early discharge.

MEDICATION ASSESSMENT

BETA BLOCKERS

There is overwhelming evidence for the benefits of early use of beta blocker in patients with STEMI and no contraindications to their use. Studies have demonstrated benefits of their use in patients with and without concomitant fibri-nolytic therapy, as well-as; not only-but also; not only-but; not alone-but early and late after STEMI.